The high cost of prescription eye medications affects over 2 million Americans dealing with vision problems. Patient Assistance Programs (PAPs) offer a vital solution for the underinsured and ...
Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...
The Lupus Foundation of America knows that it is difficult to live with lupus. The cost of living with this cruel disease can put a strain on your financial resources. Below we have put together a ...
On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
On June 17, 2024, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted a favorable Advisory Opinion 24-03 (“AO 24-03”) involving a pharmaceutical manufacturer’s ...
Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting ...
Leemore Dafny ([email protected]), Harvard University, Boston, Massachusetts. Christopher Ody, Northwestern University, Evanston, Illinois. Teresa Rokos, University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results